RenovoRx Inc (RNXT) Live Share Price, Invest From India

RenovoRx Inc Stock Performance

as on May 8, 2026 at 2:15 pm IST

Day's High
$0.88
Day's Price Range
$0.93
$0.88
5.68%
Upside
52 Week's Low
52 Week's High
$0.70
52-Week Price Range
$1.45
$0.88
20.39%
Downside
64.77%
Upside

RenovoRx Inc share price movements today

Previous Close: $0.89
Open: $0.90
Volume: 394.9K
Day's Low - High: $0.88 - $0.93
52 Week Low - High: $0.70 - $1.45

RenovoRx Inc Historical Returns

1 Month Return: -1.12 %
3 Month Return: -10.11 %
1 Year Return: -15.65 %
3 Year Return: -67.16 %
5 Year Return: 0 %

RenovoRx Inc Stock Fundamentals & Key Indicators

Check RenovoRx Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$41.8M

EPS (TTM)

-0.2867

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-12.0M

Revenue (TTM)

1.1M

Profit Margin

0.00%

Return On Equity TTM

-225.62%

RenovoRx Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of RenovoRx Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
RenovoRx Inc	BUY	$41.8M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$40.5B	130.77%	76.32	12.55%
BeiGene, Ltd.	NA	$32.5B	NA	70.89	5.37%
Vertex Pharmaceuticals Inc	BUY	$108.5B	98.9%	25.38	35.51%
Regeneron Pharmaceuticals Inc	BUY	$75.6B	45.15%	17.6	29.65%

Stock Returns calculator for RenovoRx Inc Stock including INR - Dollar returns

The RenovoRx Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

RenovoRx Inc investment value today

Current value as on today

₹93,226

Returns

-₹6,774

(-6.77%)

Returns from RenovoRx Inc Stock

-₹16,190 (-16.19%)

Dollar Impact

₹9,416 (+9.42%)

Analyst Recommendation on RenovoRx Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for RenovoRx Inc. Average target price of $6.88

RenovoRx Inc Share Price Target

Get share price movements and forecasts by analysts on RenovoRx Inc.

What analysts predicted

87.21%UPSIDE

Target Price

$6.88

Current Price

$0.88

Analyzed by

9 Analysts

Target

$6.88

RenovoRx Inc target price $6.88, a slight upside of 87.21% compared to current price of $0.88. According to 9 analysts rating.

Indian Investors' Interest in RenovoRx Inc Stock

Search interest for RenovoRx Inc Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 8, 2026 to May 8, 2026

Change:-25% versus previous 30 day period

RenovoRx Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	0	0	0	0	0
Gross Profit	-	-	-	-	-	-	0	0	0	0
Operating Income	-2	-1	-2	-3	-2	-2	-3	-2	-3	-3
EBITDA	-2	-	-2	-3	-2	-	-2	-2	-2	-3
Interest Expense	-	-	0	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	0	0	0	0
Income Before Tax	-1	-3	-1	-2	-2	-2	-2	-2	-2	-2
Income Tax Expense	0	-	-2	-3	-	-	2	-	-	-
Net Income	-1	-3	-1	-2	-2	-2	-2	-2	-2	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-6693.02%	-1228.43%	-686.02%	-1094.74%	-1235.71%

RenovoRx Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	0	1
Gross Profit	-	-	0	0	-	0	0
Operating Income	-3	-3	-5	-9	-11	-10	-12
EBITDA	-3	-3	-5	-9	-11	-10	-12
Interest Expense	-	0	0	0	0	0	-
Depreciation	-	-	0	0	-	-	0
Income Before Tax	-3	-3	-6	-9	-10	-8	-11
Income Tax Expense	0	0	0	0	0	-8	-
Net Income	-3	-3	-6	-9	-10	-8	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-20497.67%	-994.48%

RenovoRx Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-3	-1	-2	-2	-2	-2	-2	-2	-2
Operating Cash Flow	-2	-2	-2	-2	-2	-3	-2	-2	-3
Investing Cash Flow	-	-	-	-	-	0	-	-	-
Financing Cash Flow	-	5	9	0	0	10	0	-	-
Change in Cash	-2	3	7	-2	-2	7	-2	-2	-3

RenovoRx Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-3	-6	-9	-10	-8	-11
Operating Cash Flow	-3	-5	-8	-10	-9	-10
Investing Cash Flow	0	0	-2	2	0	0
Financing Cash Flow	3	19	0	5	15	10
Change in Cash	0	13	-10	-3	5	0

Global Institutional Holdings in RenovoRx Inc

Funds	Holdings
Bleichroeder LP	1.47%
AIGH Capital Management, LLC	6.29%
Sontag Advisory LLC	0.56%
Kestra Advisory Services, LLC	0.1%
Citadel Advisors Llc	0.33%

See all

Insights on RenovoRx Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 23.4% return, outperforming this stock by 91.3%
NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 32.8% return, outperforming this stock by 47.2%
NEGATIVE IMPACT
Price Dip
In the last 1 month, RNXT stock has moved down by -5.2%

About RenovoRx Inc

RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.

Organisation	RenovoRx Inc
Headquarters	2570 West El Camino Real, Mountain View, CA, United States, 94040
Industry	Biotechnology
CEO	Mr. Shaun R. Bagai
E-voting on shares	Click here to vote

Key Management of RenovoRx Inc

Name	Title
Mr. Shaun R. Bagai	CEO, Secretary & Director
Mr. Mark Voll	CFO & Principal Accounting Officer
Mr. Robert Strasser	Vice President of Operations and R&D

FAQs

What is RenovoRx Inc share price today?

RenovoRx Inc share price today is $0.88 as on May 8, 2026 at 8:45 am IST at the close of the market. RenovoRx Inc share today touched a day high of $0.93 and a low of $0.88.

What is the 52 week high and 52 week low for RenovoRx Inc share?

RenovoRx Inc share touched a 52 week high of $1.45 on September 19, 2025 and a 52 week low of $0.7 on November 14, 2025. RenovoRx Inc stock price today i.e. May 8, 2026 at 8:45 am IST is closed at $0.88,which is 39.31% down from its 52 week high and 25.61% up from its 52 week low.

What is RenovoRx Inc's market capitalisation today?

RenovoRx Inc market capitalisation is $0.00T as on May 8, 2026 at 8:45 am IST.

How to invest in RenovoRx Inc Stock (RNXT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for RenovoRx Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in RenovoRx Inc Shares that will get you 1.7045 shares as per RenovoRx Inc share price of $0.88 per share as on May 8, 2026 at 8:45 am IST.

What is the minimum amount required to buy RenovoRx Inc Stock (RNXT) from India?

Indian investors can start investing in RenovoRx Inc (RNXT) shares with as little as ₹94.24 or $1 (as of May 8, 2026 at 9:45 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in RenovoRx Inc stock (as per the Rupee-Dollar exchange rate as on May 8, 2026 at 9:45 am IST). Based on RenovoRx Inc share’s latest price of $0.88 as on May 8, 2026 at 8:45 am IST, you will get 11.3636 shares of RenovoRx Inc. Learn more about fractional shares .